October 18, 2021
Video
An expert discusses the future of metastatic castrate-resistant prostate cancer management.
October 18, 2021
Video
Karim Fizazi, MD, PhD, reviews darolutamide data in prostate cancer, including data from phase II clinical trial, ODENZA.
October 18, 2021
Video
A key opinion leader discusses impact of ADTs on brain and cognitive function in men with prostate cancer.
October 18, 2021
Video
Dr. Karim Fizazi describes the use of next generation androgen receptor inhibitors in treatment of metastatic castrate-resistant prostate cancer.
October 18, 2021
Video
An oncologist explains treatment selection and the systemic therapy options available for patients with metastatic castrate-resistant prostate cancer.
October 18, 2021
Video
Karim Fizazi, MD, PhD, provides an overview of advances in treatment of metastatic castrate-resistant prostate cancer.